You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 1, January 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE TENTH ANNUAL MEETING OF THE SURGICAL INFECTION SOCIETY, CINCINNATI, OHIO, June 15, 1990-PART I
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Effects of Granulocyte-Macrophage Colony-Stimulating Factor in Burn Patients

MAJ William G. Cioffi, Jr, MC; LTC David G. Burleson, PhD; Bryan S. Jordan, MS; LTC William K. Becker, MC; COL William F. McManus, MC; Arthur D. Mason, Jr, MD; COL Basil A. Pruitt, Jr, MC

Arch Surg. 1991;126(1):74-79.


Abstract

• We studied the effects of granulocyte-macrophage colony-stimulating factor in burn patients. Serial measurements of granulocyte oxidative function were obtained in treated patients and in a group of controls matched for age and total burn size. The administration of granulocyte-macrophage colony-stimulating factor resulted in a 50% increase in mean leukocyte counts. Both groups showed significant baseline increases in granulocytic cytosolic oxidative function. Treated patients showed normal stimulated cytosolic oxidative function, which was significantly depressed compared with that of untreated patients. Myeloper-oxidase activity was increased in treated patients during the first postburn week but then declined to normal levels. Untreated patients had a significant increase in myeloperoxidase activity for the first 3 weeks following injury. Untreated patients exhibited a significant decrease in superoxide activity during the second 3 weeks following injury. Treated patients demonstrated normal superoxide activity.

(Arch Surg. 1991; 126:74-79)



Author Affiliations

USA; USA; USA; USA

From the US Army Institute of Surgical Research, Fort Sam Houston, San Antonio, Tex.


Footnotes

Accepted for publication September 29, 1990.

Read before the Tenth Anniversary Meeting of the Surgical Infection Society, Cincinnati, Ohio, June 15, 1990.

The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense.

Reprint requests to the US Army Institute of Surgical Research, Fort Sam Houston, San Antonio, TX 78234-5012 (Dr Pruitt).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effect of Granulocyte-Monocyte Colony-Stimulating Factor Therapy on Leukocyte Function and Clearance of Serious Infection in Nonneutropenic Patients
Rosenbloom et al.
Chest 2005;127:2139-2150.
ABSTRACT | FULL TEXT  

Enhancement of Dendritic Cell Production by Fms-Like Tyrosine Kinase-3 Ligand Increases the Resistance of Mice to a Burn Wound Infection
Toliver-Kinsky et al.
J. Immunol. 2005;174:404-410.
ABSTRACT | FULL TEXT  

Stimulation of Hematopoiesis by the Fms-Like Tyrosine Kinase 3 Ligand Restores Bacterial Induction of Th1 Cytokines in Thermally Injured Mice
Toliver-Kinsky et al.
Infect. Immun. 2003;71:3058-3067.
ABSTRACT | FULL TEXT  

The Horror Autotoxicus and Multiple-Organ Failure
Baue
Arch Surg 1992;127:1451-1462.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.